The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Medication Market Research Report 2025
Synopsis
The global Pet Medication market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 46%.
This report aims to provide a comprehensive presentation of the global market for Pet Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Medication.
Report Scope
The Pet Medication market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Segment by Type
Antibiotics
Antifungal
Flea Products
Segment by Application
Cat
Dog
Horse
Fish
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pet Medication market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 46%.
This report aims to provide a comprehensive presentation of the global market for Pet Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Medication.
Report Scope
The Pet Medication market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Segment by Type
Antibiotics
Antifungal
Flea Products
Segment by Application
Cat
Dog
Horse
Fish
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pet Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pet Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pet Medication Market Overview
1.1 Product Overview and Scope of Pet Medication
1.2 Pet Medication Segment by Type
1.2.1 Global Pet Medication Market Value Comparison by Type (2024-2030)
1.2.2 Antibiotics
1.2.3 Antifungal
1.2.4 Flea Products
1.3 Pet Medication Segment by Application
1.3.1 Global Pet Medication Market Value by Application: (2024-2030)
1.3.2 Cat
1.3.3 Dog
1.3.4 Horse
1.3.5 Fish
1.3.6 Others
1.4 Global Pet Medication Market Size Estimates and Forecasts
1.4.1 Global Pet Medication Revenue 2019-2030
1.4.2 Global Pet Medication Sales 2019-2030
1.4.3 Global Pet Medication Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pet Medication Market Competition by Manufacturers
2.1 Global Pet Medication Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pet Medication Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pet Medication Average Price by Manufacturers (2019-2024)
2.4 Global Pet Medication Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pet Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Medication, Product Type & Application
2.7 Pet Medication Market Competitive Situation and Trends
2.7.1 Pet Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Medication Players Market Share by Revenue
2.7.3 Global Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Medication Retrospective Market Scenario by Region
3.1 Global Pet Medication Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pet Medication Global Pet Medication Sales by Region: 2019-2030
3.2.1 Global Pet Medication Sales by Region: 2019-2024
3.2.2 Global Pet Medication Sales by Region: 2025-2030
3.3 Global Pet Medication Global Pet Medication Revenue by Region: 2019-2030
3.3.1 Global Pet Medication Revenue by Region: 2019-2024
3.3.2 Global Pet Medication Revenue by Region: 2025-2030
3.4 North America Pet Medication Market Facts & Figures by Country
3.4.1 North America Pet Medication Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pet Medication Sales by Country (2019-2030)
3.4.3 North America Pet Medication Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Medication Market Facts & Figures by Country
3.5.1 Europe Pet Medication Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pet Medication Sales by Country (2019-2030)
3.5.3 Europe Pet Medication Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Medication Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pet Medication Sales by Country (2019-2030)
3.6.3 Asia Pacific Pet Medication Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Medication Market Facts & Figures by Country
3.7.1 Latin America Pet Medication Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pet Medication Sales by Country (2019-2030)
3.7.3 Latin America Pet Medication Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Medication Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pet Medication Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pet Medication Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pet Medication Sales by Type (2019-2030)
4.1.1 Global Pet Medication Sales by Type (2019-2024)
4.1.2 Global Pet Medication Sales by Type (2025-2030)
4.1.3 Global Pet Medication Sales Market Share by Type (2019-2030)
4.2 Global Pet Medication Revenue by Type (2019-2030)
4.2.1 Global Pet Medication Revenue by Type (2019-2024)
4.2.2 Global Pet Medication Revenue by Type (2025-2030)
4.2.3 Global Pet Medication Revenue Market Share by Type (2019-2030)
4.3 Global Pet Medication Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pet Medication Sales by Application (2019-2030)
5.1.1 Global Pet Medication Sales by Application (2019-2024)
5.1.2 Global Pet Medication Sales by Application (2025-2030)
5.1.3 Global Pet Medication Sales Market Share by Application (2019-2030)
5.2 Global Pet Medication Revenue by Application (2019-2030)
5.2.1 Global Pet Medication Revenue by Application (2019-2024)
5.2.2 Global Pet Medication Revenue by Application (2025-2030)
5.2.3 Global Pet Medication Revenue Market Share by Application (2019-2030)
5.3 Global Pet Medication Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Pet Medication Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Pet Medication Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Elanco
6.3.1 Elanco Corporation Information
6.3.2 Elanco Description and Business Overview
6.3.3 Elanco Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Elanco Pet Medication Product Portfolio
6.3.5 Elanco Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Pet Medication Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Boehringer
6.5.1 Boehringer Corporation Information
6.5.2 Boehringer Description and Business Overview
6.5.3 Boehringer Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Pet Medication Product Portfolio
6.5.5 Boehringer Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Pet Medication Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Virbac Pet Medication Product Portfolio
6.7.5 Virbac Recent Developments/Updates
6.8 Ceva
6.8.1 Ceva Corporation Information
6.8.2 Ceva Description and Business Overview
6.8.3 Ceva Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ceva Pet Medication Product Portfolio
6.8.5 Ceva Recent Developments/Updates
6.9 Vetoquinol
6.9.1 Vetoquinol Corporation Information
6.9.2 Vetoquinol Description and Business Overview
6.9.3 Vetoquinol Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vetoquinol Pet Medication Product Portfolio
6.9.5 Vetoquinol Recent Developments/Updates
6.10 Nexvet
6.10.1 Nexvet Corporation Information
6.10.2 Nexvet Description and Business Overview
6.10.3 Nexvet Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nexvet Pet Medication Product Portfolio
6.10.5 Nexvet Recent Developments/Updates
6.11 Aratana Therapeutics
6.11.1 Aratana Therapeutics Corporation Information
6.11.2 Aratana Therapeutics Pet Medication Description and Business Overview
6.11.3 Aratana Therapeutics Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Aratana Therapeutics Pet Medication Product Portfolio
6.11.5 Aratana Therapeutics Recent Developments/Updates
6.12 Kindred Biosciences
6.12.1 Kindred Biosciences Corporation Information
6.12.2 Kindred Biosciences Pet Medication Description and Business Overview
6.12.3 Kindred Biosciences Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kindred Biosciences Pet Medication Product Portfolio
6.12.5 Kindred Biosciences Recent Developments/Updates
6.13 Ambrx
6.13.1 Ambrx Corporation Information
6.13.2 Ambrx Pet Medication Description and Business Overview
6.13.3 Ambrx Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Ambrx Pet Medication Product Portfolio
6.13.5 Ambrx Recent Developments/Updates
6.14 Entest Biomedical
6.14.1 Entest Biomedical Corporation Information
6.14.2 Entest Biomedical Pet Medication Description and Business Overview
6.14.3 Entest Biomedical Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Entest Biomedical Pet Medication Product Portfolio
6.14.5 Entest Biomedical Recent Developments/Updates
6.15 Taconic Biosciences
6.15.1 Taconic Biosciences Corporation Information
6.15.2 Taconic Biosciences Pet Medication Description and Business Overview
6.15.3 Taconic Biosciences Pet Medication Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Taconic Biosciences Pet Medication Product Portfolio
6.15.5 Taconic Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Medication Industry Chain Analysis
7.2 Pet Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Medication Production Mode & Process
7.4 Pet Medication Sales and Marketing
7.4.1 Pet Medication Sales Channels
7.4.2 Pet Medication Distributors
7.5 Pet Medication Customers
8 Pet Medication Market Dynamics
8.1 Pet Medication Industry Trends
8.2 Pet Medication Market Drivers
8.3 Pet Medication Market Challenges
8.4 Pet Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pet Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pet Medication Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Pet Medication Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pet Medication Sales (K MT) of Key Manufacturers (2019-2024)
Table 5. Global Pet Medication Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pet Medication Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pet Medication Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pet Medication Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pet Medication, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pet Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pet Medication, Product Type & Application
Table 12. Global Key Manufacturers of Pet Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pet Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Medication as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pet Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pet Medication Sales by Region (2019-2024) & (K MT)
Table 18. Global Pet Medication Sales Market Share by Region (2019-2024)
Table 19. Global Pet Medication Sales by Region (2025-2030) & (K MT)
Table 20. Global Pet Medication Sales Market Share by Region (2025-2030)
Table 21. Global Pet Medication Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pet Medication Revenue Market Share by Region (2019-2024)
Table 23. Global Pet Medication Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pet Medication Revenue Market Share by Region (2025-2030)
Table 25. North America Pet Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pet Medication Sales by Country (2019-2024) & (K MT)
Table 27. North America Pet Medication Sales by Country (2025-2030) & (K MT)
Table 28. North America Pet Medication Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pet Medication Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pet Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pet Medication Sales by Country (2019-2024) & (K MT)
Table 32. Europe Pet Medication Sales by Country (2025-2030) & (K MT)
Table 33. Europe Pet Medication Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pet Medication Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pet Medication Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pet Medication Sales by Region (2019-2024) & (K MT)
Table 37. Asia Pacific Pet Medication Sales by Region (2025-2030) & (K MT)
Table 38. Asia Pacific Pet Medication Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pet Medication Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pet Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pet Medication Sales by Country (2019-2024) & (K MT)
Table 42. Latin America Pet Medication Sales by Country (2025-2030) & (K MT)
Table 43. Latin America Pet Medication Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pet Medication Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Pet Medication Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Pet Medication Sales by Country (2019-2024) & (K MT)
Table 47. Middle East & Africa Pet Medication Sales by Country (2025-2030) & (K MT)
Table 48. Middle East & Africa Pet Medication Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pet Medication Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pet Medication Sales (K MT) by Type (2019-2024)
Table 51. Global Pet Medication Sales (K MT) by Type (2025-2030)
Table 52. Global Pet Medication Sales Market Share by Type (2019-2024)
Table 53. Global Pet Medication Sales Market Share by Type (2025-2030)
Table 54. Global Pet Medication Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pet Medication Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pet Medication Revenue Market Share by Type (2019-2024)
Table 57. Global Pet Medication Revenue Market Share by Type (2025-2030)
Table 58. Global Pet Medication Price (USD/MT) by Type (2019-2024)
Table 59. Global Pet Medication Price (USD/MT) by Type (2025-2030)
Table 60. Global Pet Medication Sales (K MT) by Application (2019-2024)
Table 61. Global Pet Medication Sales (K MT) by Application (2025-2030)
Table 62. Global Pet Medication Sales Market Share by Application (2019-2024)
Table 63. Global Pet Medication Sales Market Share by Application (2025-2030)
Table 64. Global Pet Medication Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pet Medication Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pet Medication Revenue Market Share by Application (2019-2024)
Table 67. Global Pet Medication Revenue Market Share by Application (2025-2030)
Table 68. Global Pet Medication Price (USD/MT) by Application (2019-2024)
Table 69. Global Pet Medication Price (USD/MT) by Application (2025-2030)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 73. Zoetis Pet Medication Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 78. Merck Pet Medication Product
Table 79. Merck Recent Developments/Updates
Table 80. Elanco Corporation Information
Table 81. Elanco Description and Business Overview
Table 82. Elanco Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 83. Elanco Pet Medication Product
Table 84. Elanco Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 88. Bayer Pet Medication Product
Table 89. Bayer Recent Developments/Updates
Table 90. Boehringer Corporation Information
Table 91. Boehringer Description and Business Overview
Table 92. Boehringer Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 93. Boehringer Pet Medication Product
Table 94. Boehringer Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 98. Novartis Pet Medication Product
Table 99. Novartis Recent Developments/Updates
Table 100. Virbac Corporation Information
Table 101. Virbac Description and Business Overview
Table 102. Virbac Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 103. Virbac Pet Medication Product
Table 104. Virbac Recent Developments/Updates
Table 105. Ceva Corporation Information
Table 106. Ceva Description and Business Overview
Table 107. Ceva Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 108. Ceva Pet Medication Product
Table 109. Ceva Recent Developments/Updates
Table 110. Vetoquinol Corporation Information
Table 111. Vetoquinol Description and Business Overview
Table 112. Vetoquinol Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 113. Vetoquinol Pet Medication Product
Table 114. Vetoquinol Recent Developments/Updates
Table 115. Nexvet Corporation Information
Table 116. Nexvet Description and Business Overview
Table 117. Nexvet Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 118. Nexvet Pet Medication Product
Table 119. Nexvet Recent Developments/Updates
Table 120. Aratana Therapeutics Corporation Information
Table 121. Aratana Therapeutics Description and Business Overview
Table 122. Aratana Therapeutics Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 123. Aratana Therapeutics Pet Medication Product
Table 124. Aratana Therapeutics Recent Developments/Updates
Table 125. Kindred Biosciences Corporation Information
Table 126. Kindred Biosciences Description and Business Overview
Table 127. Kindred Biosciences Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 128. Kindred Biosciences Pet Medication Product
Table 129. Kindred Biosciences Recent Developments/Updates
Table 130. Ambrx Corporation Information
Table 131. Ambrx Description and Business Overview
Table 132. Ambrx Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 133. Ambrx Pet Medication Product
Table 134. Ambrx Recent Developments/Updates
Table 135. Entest Biomedical Corporation Information
Table 136. Entest Biomedical Description and Business Overview
Table 137. Entest Biomedical Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 138. Entest Biomedical Pet Medication Product
Table 139. Entest Biomedical Recent Developments/Updates
Table 140. Taconic Biosciences Corporation Information
Table 141. Taconic Biosciences Description and Business Overview
Table 142. Taconic Biosciences Pet Medication Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 143. Taconic Biosciences Pet Medication Product
Table 144. Taconic Biosciences Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pet Medication Distributors List
Table 148. Pet Medication Customers List
Table 149. Pet Medication Market Trends
Table 150. Pet Medication Market Drivers
Table 151. Pet Medication Market Challenges
Table 152. Pet Medication Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Medication
Figure 2. Global Pet Medication Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pet Medication Market Share by Type in 2023 & 2030
Figure 4. Antibiotics Product Picture
Figure 5. Antifungal Product Picture
Figure 6. Flea Products Product Picture
Figure 7. Global Pet Medication Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Pet Medication Market Share by Application in 2023 & 2030
Figure 9. Cat
Figure 10. Dog
Figure 11. Horse
Figure 12. Fish
Figure 13. Others
Figure 14. Global Pet Medication Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Pet Medication Market Size (2019-2030) & (US$ Million)
Figure 16. Global Pet Medication Sales (2019-2030) & (K MT)
Figure 17. Global Pet Medication Average Price (USD/MT) & (2019-2030)
Figure 18. Pet Medication Report Years Considered
Figure 19. Pet Medication Sales Share by Manufacturers in 2023
Figure 20. Global Pet Medication Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Pet Medication Players: Market Share by Revenue in 2023
Figure 22. Pet Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Pet Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Pet Medication Sales Market Share by Country (2019-2030)
Figure 25. North America Pet Medication Revenue Market Share by Country (2019-2030)
Figure 26. U.S. Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Pet Medication Sales Market Share by Country (2019-2030)
Figure 29. Europe Pet Medication Revenue Market Share by Country (2019-2030)
Figure 30. Germany Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Pet Medication Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Pet Medication Revenue Market Share by Region (2019-2030)
Figure 37. China Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Taiwan Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Indonesia Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Thailand Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Malaysia Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Philippines Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Pet Medication Sales Market Share by Country (2019-2030)
Figure 48. Latin America Pet Medication Revenue Market Share by Country (2019-2030)
Figure 49. Mexico Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Brazil Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Argentina Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Middle East & Africa Pet Medication Sales Market Share by Country (2019-2030)
Figure 53. Middle East & Africa Pet Medication Revenue Market Share by Country (2019-2030)
Figure 54. Turkey Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. UAE Pet Medication Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Global Sales Market Share of Pet Medication by Type (2019-2030)
Figure 58. Global Revenue Market Share of Pet Medication by Type (2019-2030)
Figure 59. Global Pet Medication Price (USD/MT) by Type (2019-2030)
Figure 60. Global Sales Market Share of Pet Medication by Application (2019-2030)
Figure 61. Global Revenue Market Share of Pet Medication by Application (2019-2030)
Figure 62. Global Pet Medication Price (USD/MT) by Application (2019-2030)
Figure 63. Pet Medication Value Chain
Figure 64. Pet Medication Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
